ImmunoGen Balance Sheet Health

Financial Health criteria checks 4/6

ImmunoGen has a total shareholder equity of $561.6M and total debt of $72.1M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are $822.1M and $260.5M respectively.

Key information

12.8%

Debt to equity ratio

US$72.11m

Debt

Interest coverage ration/a
CashUS$605.54m
EquityUS$561.60m
Total liabilitiesUS$260.51m
Total assetsUS$822.10m

Recent financial health updates

Recent updates

Final Countdown: AbbVie's Imminent Closure With ImmunoGen And What It Means

Feb 09

ImmunoGen, Inc.'s (NASDAQ:IMGN) Intrinsic Value Is Potentially 40% Above Its Share Price

Jan 09
ImmunoGen, Inc.'s (NASDAQ:IMGN) Intrinsic Value Is Potentially 40% Above Its Share Price

There's Reason For Concern Over ImmunoGen, Inc.'s (NASDAQ:IMGN) Massive 95% Price Jump

Dec 22
There's Reason For Concern Over ImmunoGen, Inc.'s (NASDAQ:IMGN) Massive 95% Price Jump

ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely

Oct 20
ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely

Analysts Just Made A Massive Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN) Forecasts

Aug 06
Analysts Just Made A Massive Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN) Forecasts

Is ImmunoGen, Inc. (NASDAQ:IMGN) Trading At A 48% Discount?

Jul 20
Is ImmunoGen, Inc. (NASDAQ:IMGN) Trading At A 48% Discount?

Forecast: Analysts Think ImmunoGen, Inc.'s (NASDAQ:IMGN) Business Prospects Have Improved Drastically

May 03
Forecast: Analysts Think ImmunoGen, Inc.'s (NASDAQ:IMGN) Business Prospects Have Improved Drastically

ImmunoGen, Inc.'s (NASDAQ:IMGN) Low P/S No Reason For Excitement

Apr 18
ImmunoGen, Inc.'s (NASDAQ:IMGN) Low P/S No Reason For Excitement

Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?

Feb 25
Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?

What Does The Future Hold For ImmunoGen, Inc. (NASDAQ:IMGN)? These Analysts Have Been Cutting Their Estimates

Jan 03
What Does The Future Hold For ImmunoGen, Inc. (NASDAQ:IMGN)? These Analysts Have Been Cutting Their Estimates

Financial Position Analysis

Short Term Liabilities: IMGN's short term assets ($766.9M) exceed its short term liabilities ($134.7M).

Long Term Liabilities: IMGN's short term assets ($766.9M) exceed its long term liabilities ($125.8M).


Debt to Equity History and Analysis

Debt Level: IMGN has more cash than its total debt.

Reducing Debt: IMGN's debt to equity ratio has increased from 4.4% to 12.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IMGN has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if IMGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies